Elmira Sager
Adult Health · Hixson, TNNPI 1811944770
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 165 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,230, 8.9 times the $138 reported in 2021.
Across 165 payments — averaging $20.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$785
- AstraZeneca$553
- Lilly USA, LLC$273
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$252
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$246
- Otsuka America Pharmaceutical, Inc.$229
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,413100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 42 | $785 |
| AstraZeneca | 17 | $553 |
| Lilly USA, LLC | 17 | $273 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $252 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $246 |
| Otsuka America Pharmaceutical, Inc. | 11 | $229 |
| AbbVie | 9 | $160 |
| Amgen | 8 | $141 |
| Eisai Inc. | 1 | $122 |
| Bayer | 5 | $120 |
| Lundbeck LLC | 4 | $91 |
| Pfizer | 5 | $80 |
| Merck | 3 | $46 |
| Alkermes, Inc. | 2 | $46 |
| Novartis | 2 | $40 |
| Boston Scientific | 2 | $38 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Neurocrine Biosciences, Inc. | 1 | $25 |
| Viatris Specialty LLC | 1 | $24 |
| Corcept Therapeutics | 1 | $22 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Verona Pharma, Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,413 in reported general payments places this provider in the 80th percentile of 352 adult health providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 18 | $53 |
Paid to pharmacies, not to this prescriber.
Other adult health in Hixson
- Marwan MoughrabiHixson$15K
- Carley McCloskeyHixson$3K
- Brenda BaxterNashville$246K
- Artangela HenryMemphis$74K
- Luisa LealNashville$49K
- Robbie LeinartKnoxville$48K
- Terrye MastinMemphis$34K
- Marshe TurnerMemphis$21K
- Sonya KnightSevierville$17K
- Emily LeidigBristol$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.